Open help menu
Live Webinar

The Clinical Ethics of AI in Mental Health

|

Information

Date & Time

Description

This presentation on the clinical ethics of generative AI (artificial intelligence) introduces a four-domain framework of mental health risk associated with AI chatbot use, including emotional attachment, reality-testing impairment, crisis safety concerns, and ethical issues such as privacy, bias, and confidentiality. Clinicians will be able to recognize patterns of maladaptive or higher-risk AI use that warrant clinical assessment and understand the ethical risks of AI use in therapeutic contexts, including both client-facing and clinician-facing AI.

Educational Goal

The educational goal for this presentation is to educate clinicians how to evaluate and engage with AI systems ethically, including preserving patient privacy, confidentiality, and the therapeutic alliance. They will be able to identify and analyze patterns of maladaptive or higher-risk AI use warranting clinical assessment.

Learning Objectives

Participants will be able to:

  • Identify patterns of maladaptive or higher-risk generative AI use.

  • Describe a four-domain framework of mental health risks associated with AI chatbot use, including emotional attachment, reality-testing impairment, crisis safety concerns, and ethical issues, such as privacy and bias.

  • Analyze the ethical risks of shadow AI use in clinical contexts, including patient and clinician AI use in therapeutic contexts and considerations of informed consent, confidentiality, and the therapeutic alliance.

Target Audience

  • Addiction Professional
  • Counselor
  • Marriage & Family Therapist
  • Nurse
  • Physician
  • Psychologist
  • Social Worker

Presenters

Marlynn Wei, MD, JD
Dr. Marlynn Wei, MD, JD, is a Harvard-trained psychiatrist, psychodynamic psychotherapist, and author working at the intersection of artificial intelligence and mental health. With a background in law, her work examines emerging clinical and ethical issues related to AI, including AI therapy, cognitive impact, and digital immortality. Dr. Wei has testified before the U.S. Congress on the mental health risks and benefits of AI chatbots and has appeared on Fox Business, PBS, and CBS Mornings. She maintains a psychotherapy practice in New York City and has a forthcoming book with MIT Press, Unreal: Finding Truth in the Age of AI Psychosis.
Robert J. Boland, MD
Robert J. Boland, MD, is a distinguished psychiatrist specializing in Medical Education, Medical Psychiatry, and Geriatric Psychiatry. He is a Professor of Psychiatry and holds the Brown Foundation Endowed Chair in Psychiatry at Baylor College of Medicine. Dr. Boland’s career is marked by his extensive experience in clinical leadership, education, and administration, with a particular focus on innovative pedagogical approaches and technology integration into medical education. Dr. Boland completed his undergraduate studies in Biology at Georgetown University and his medical degree at Georgetown University School of Medicine. He pursued his Psychiatry Residency at The Institute of Living in Hartford, Connecticut, and further specialized with a Consultation-Liaison Psychiatry Fellowship at Georgetown University/Fairfax Hospital in Virginia. Dr. Boland previously held faculty positions at Brown University and Harvard Medical School. In his current role, he oversees the clinical staff at Baylor College of Medicine. and as a training director at the Brigham and Women’s Hospital and Brown University. Dr. Boland is a Director at the American Board of Psychiatry and Neurology and a previous chair of the Psychiatry Residency Review Committee at the Accreditation Council for Graduate Medical Education. Additionally, he is the chair of the American Board of Medical Specialties’ Committee on Certification. His research contributions have focused on areas of innovative teaching methods, assessment systems, and the interface between psychiatry and medicine. Dr. Boland has published numerous peer-reviewed articles and book chapters and has co-edited several influential psychiatric textbooks, earning multiple awards and honors, including the Lifetime Achievement Award from the Association for Academic Psychiatry in 2022 and numerous Outstanding Teaching Awards. Dr. Boland is actively involved in several professional societies, including the American Board of Psychiatry and Neurology, where he serves on the Board of Directors, and is a past president of the Academy of Consultation-Liaison Psychiatry, the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry.

Financially Sponsored By

  • The Menninger Clinic